Literature DB >> 34716880

Targeted design of green carbon dot-CA-125 aptamer conjugate for the fluorescence imaging of ovarian cancer cell.

Fatemeh Heidari1,2, Nasrin Mohajeri3, Nosratollah Zarghami4,5,6,7.   

Abstract

Aptamer-Carbon Dot (CD) bioconjugation is an attractive target-tracking strategy in detecting cell surface antigens. This study describes an effective imaging paradigm for CA-125 antigen imaging. Our experience encompasses green CD synthesis and characterization, CD-capture probe conjugation through covalent bonding, the hybridization linkage of CD-probe to aptamer and their coupling confirmation, and fluorescent targeted imaging of ovarian cancer cells. As a result, the synthesized CDs from lemon extract by hydrothermal reaction show average size of 2 nm with maximum fluorescence intensity at excitation/emission 360/450 nm. CD-probe construction was provided by functional group interactions of CD and probe via EDC/NHS chemistry. The linkage of CD-probe to aptamer was conducted by Watson-Crick nucleotide pairing. The assessment of CD-probe and CD-probe-aptamer fabrication was validated by the increase in surface roughness through AFM analysis, the diminish of fluorescence intensity of CD after bioconjugation, and particle size growth of the construct. Conjugates with negligible cytotoxicity, appropriate zeta potential, and good aptamer release were applied in cellular imaging. This targeted diagnosis method was employed the four reported DNA aptamers toward fluorescence intensity. The DOV-3 aptamer showed more qualified detection over other aptamer conjugates during fluorescent microscopy analysis. In conclusion, the CD-probe-aptamer conjugate applications as toxic-free method can open new horizons in fluorescent nano-imaging in the field of targeted cancer cell diagnosis.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bioconjugation; Cell Surface Biomarker; Epithelial Ovarian Cancer; Green Carbon Dot; Hybridization

Mesh:

Substances:

Year:  2021        PMID: 34716880     DOI: 10.1007/s12013-021-01034-4

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  34 in total

Review 1.  Biomarker detection technologies and future directions.

Authors:  Satish Balasaheb Nimse; Mukesh Digambar Sonawane; Keum-Soo Song; Taisun Kim
Journal:  Analyst       Date:  2015-11-19       Impact factor: 4.616

Review 2.  An update on advances in new developing DNA conjugation diagnostics and ultra-resolution imaging technologies: Possible applications in medical and biotechnological utilities.

Authors:  Nasrin Mohajeri; Mahsa Imani; Ebrahim Mostafavi; Abolfazl Akbarzadeh; Alireza Sadighi; Nosratollah Zarghami
Journal:  Biosens Bioelectron       Date:  2019-08-28       Impact factor: 10.618

3.  Direct, Real-Time Detection of Adenosine Triphosphate Release from Astrocytes in Three-Dimensional Culture Using an Integrated Electrochemical Aptamer-Based Sensor.

Authors:  Mirelis Santos-Cancel; Laura W Simpson; Jennie B Leach; Ryan J White
Journal:  ACS Chem Neurosci       Date:  2019-02-20       Impact factor: 4.418

4.  Development of an ovarian cancer symptom index: possibilities for earlier detection.

Authors:  Barbara A Goff; Lynn S Mandel; Charles W Drescher; Nicole Urban; Shirley Gough; Kristi M Schurman; Joshua Patras; Barry S Mahony; M Robyn Andersen
Journal:  Cancer       Date:  2007-01-15       Impact factor: 6.860

Review 5.  Current approaches and challenges in managing and monitoring treatment response in ovarian cancer.

Authors:  Charlotte S Marcus; G Larry Maxwell; Kathleen M Darcy; Chad A Hamilton; William P McGuire
Journal:  J Cancer       Date:  2014-01-01       Impact factor: 4.207

Review 6.  Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools.

Authors:  Hunho Jo; Changill Ban
Journal:  Exp Mol Med       Date:  2016-05-06       Impact factor: 8.718

7.  Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles.

Authors:  Min Woo Kim; Hwa Yeon Jeong; Seong Jae Kang; Moon Jung Choi; Young Myoung You; Chan Su Im; Tae Sup Lee; In Ho Song; Chang Gun Lee; Ki-Jong Rhee; Yeon Kyung Lee; Yong Serk Park
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

8.  Molecular Targeting of Notch Signaling Pathway by DAPT in Human Ovarian Cancer: Possible Anti Metastatic Effects

Authors:  Maryam Akbarzadeh; Maryam Majidinia; Sedigheh Fekri Aval; Soltanali Mahbub; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2018-12-25

9.  Fluorescence-Guided Probes of Aptamer-Targeted Gold Nanoparticles with Computed Tomography Imaging Accesses for in Vivo Tumor Resection.

Authors:  Cheng-Hung Li; Tsung-Rong Kuo; Hsin-Jan Su; Wei-Yun Lai; Pan-Chyr Yang; Jinn-Shiun Chen; Di-Yan Wang; Yi-Chun Wu; Chia-Chun Chen
Journal:  Sci Rep       Date:  2015-10-28       Impact factor: 4.379

Review 10.  MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.

Authors:  Mildred Felder; Arvinder Kapur; Jesus Gonzalez-Bosquet; Sachi Horibata; Joseph Heintz; Ralph Albrecht; Lucas Fass; Justanjyot Kaur; Kevin Hu; Hadi Shojaei; Rebecca J Whelan; Manish S Patankar
Journal:  Mol Cancer       Date:  2014-05-29       Impact factor: 27.401

View more
  2 in total

1.  Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia.

Authors:  Fatemeh Memari; Vahid Tavakolpour; Nasrin Mohajeri; Behzad Poopak; Parviz Fallah; Effat Alizadeh; Fatemeh Kouhkan; Nosratollah Zarghami
Journal:  Clin Transl Oncol       Date:  2022-03-05       Impact factor: 3.405

2.  A highly sensitive strategy for glypican-3 detection based on aptamer/gold carbon dots/magnetic graphene oxide nanosheets as fluorescent biosensor.

Authors:  Guiyin Li; Wei Chen; Danhong Mi; Bo Wang; HaiMei Li; Guangxiong Wu; Ping Ding; Jintao Liang; Zhide Zhou
Journal:  Anal Bioanal Chem       Date:  2022-07-05       Impact factor: 4.478

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.